Vimedimex Medi-Pharma JSC (HOSE:VMD)

Vimedimex Medi-Pharma JSC Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Revenue	1,172,991	1,249,496	3,536,651	7,073,499	12,318,752	18,162,191
Revenue Growth (YoY)	-57.31%	-64.67%	-50.00%	-42.58%	-32.17%	-0.42%
Cost of Revenue	1,065,605	1,130,997	3,257,394	6,528,733	11,250,064	16,765,878
Gross Profit	107,387	118,499	279,256	544,766	1,068,687	1,396,313
Selling, General & Admin	112,316	112,315	244,237	512,617	915,955	1,209,996
Operating Expenses	112,316	112,315	244,237	512,617	915,955	1,209,996
Operating Income	-4,929	6,184	35,019	32,149	152,733	186,317
Interest Expense	-1,421	-3,703	-1,749	-5,107	-15,745	-7,720
Interest & Investment Income	9,712	7,413	13,437	6,954	5,519	3,095
Currency Exchange Gain (Loss)	1,017	-	-	12,540	-115,776	-140,467
Other Non Operating Income (Expenses)	31,853	21,697	-6,675	873.34	1,674	8,936
EBT Excluding Unusual Items	36,233	31,591	40,031	47,410	28,404	50,161
Gain (Loss) on Sale of Assets	-	-	-	-	29.09	250
Pretax Income	36,233	31,591	40,031	47,410	28,433	50,411
Income Tax Expense	7,768	7,024	11,768	12,256	9,084	13,316
Earnings From Continuing Operations	28,465	24,567	28,263	35,154	19,349	37,095
Minority Interest in Earnings	850.33	94.99	-2,781	-336.4	646.03	-
Net Income	29,315	24,662	25,482	34,818	19,995	37,095
Net Income to Common	29,315	24,662	25,482	34,818	19,995	37,095
Net Income Growth	37.99%	-3.22%	-26.81%	74.13%	-46.10%	18.67%
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15	15
Shares Change (YoY)	-0.01%	-0.01%	0.02%	-	-	-
EPS (Basic)	1898.33	1597.00	1650.00	2255.00	1295.00	2402.51
EPS (Diluted)	1898.33	1597.00	1650.00	2255.00	1295.00	2402.51
EPS Growth	38.02%	-3.21%	-26.83%	74.13%	-46.10%	18.67%
Free Cash Flow	209,998	116,644	5,543	696,919	-442,484	133,063
Free Cash Flow Per Share	13598.43	7553.29	358.89	45136.46	-28657.78	8617.92
Dividend Per Share	-	-	-	-	-	2000.000
Gross Margin	9.16%	9.48%	7.90%	7.70%	8.67%	7.69%
Operating Margin	-0.42%	0.50%	0.99%	0.45%	1.24%	1.03%
Profit Margin	2.50%	1.97%	0.72%	0.49%	0.16%	0.20%
Free Cash Flow Margin	17.90%	9.34%	0.16%	9.85%	-3.59%	0.73%
EBITDA	11,723	22,816	53,811	51,400	171,784	203,681
EBITDA Margin	1.00%	1.83%	1.52%	0.73%	1.39%	1.12%
D&A For EBITDA	16,652	16,632	18,792	19,251	19,051	17,364
EBIT	-4,929	6,184	35,019	32,149	152,733	186,317
EBIT Margin	-0.42%	0.50%	0.99%	0.45%	1.24%	1.03%
Effective Tax Rate	21.44%	22.23%	29.40%	25.85%	31.95%	26.41%
Revenue as Reported	1,172,991	1,249,496	3,536,651	7,073,499	12,318,752	18,162,191

Source: S&P Global Market Intelligence. Standard template. Financial Sources.